Acknowledgement
Grant : Establishment of risk management platform with aim to reduce attrition of new drugs and its service
Supported by : Ministry of Trade, Industry & Energy (MI), Ministry for Health & Welfare
References
- Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006;355:1018-1028. https://doi.org/10.1056/NEJMoa063842
- Salahudeen MS, Nishtala PS. An overview of pharmacodynamics modelling, ligand-binding approach and its application in clinical practice. Saudi Pharm J 2017;25:165-175. doi: 10.1016/j.jsps.2016.07.002.
- Black JW, Leff P. Operational model of pharmacological agonism. Proc R Soc Lond B Biol Sci 1983;220:141-162. https://doi.org/10.1098/rspb.1983.0093
- Black JW, Leff P, Shankley NP, Wood J. An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol 1985;84:561-571. https://doi.org/10.1111/j.1476-5381.1985.tb12941.x